来自干细胞的细胞外囊泡作为老年治疗药物.
Ekaterina Rudnitsky1, Alex Braiman1, Marina Wolfson1
1The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Center for Multidisciplinary Research on Aging, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
来自干细胞的细胞外囊泡 (EVs) 显示出作为老年治疗药物的前景,缓解细胞衰老及其与年龄相关的病理. 这些无细胞疗法为人类应用提供了潜在的潜力.
科学领域:
- 老年学是一门学科.
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 细胞衰老 (CS) 是一个关键的衰老特征,有助于与年龄相关的疾病.
- 累积的衰老细胞创造了一个促炎,促致癌的环境.
- 细胞外囊泡 (EVs) 调解细胞与细胞的通信,并被探索为老年治疗药物.
研究的目的:
- 审查最近关于电动汽车对细胞衰老的影响的研究.
- 讨论EVs老年治疗作用背后的机制.
- 评估干细胞衍生的EVs作为新疗法的潜力.
主要方法:
- 对研究EV和细胞衰老的研究进行文献综述.
- 从各种干细胞 (MSC,ESC,iPSC) 和非干细胞中获得的EV的分析.
- 讨论EV老年治疗效应的拟议机制.
主要成果:
- 来自干细胞的EVs (来自多能和多能源) 在体外和体内有效地减少细胞衰老表型.
- 建议EV效应是老态的,修改老化的细胞而不是消除它们.
- EVs证明了跨物种的有效性,没有观察到免疫反应.
结论:
- 来自干细胞的EV是老年治疗药物的有希望的候选者.
- 电动车为与年龄相关的疾病提供了潜在的无细胞治疗策略.
- 预计干细胞衍生的EVs在治疗衰老方面对人类有可行的应用.
更多相关视频
09:10A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
Published on: June 23, 2022
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
相关概念视频
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Mesenchymal Stem Cells
Clinical Applications of Epidermal Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
